With 2023 right around the corner, we take a moment to look and celebrate all Dealflow.eu’s achievements this year. It was amazing to support 88 ground-breaking, market ambitious EU-funded innovators, introducing them to more than 90 investors.
We organised 8 e-pitching events since our project launched in April, including last month’s Innovation Radar Prize, which resulted in four winning innovations. Many of those we have supported this year have gone on to raise growth capital – check out our success stories page for several examples.
Don’t forget: startups that have secured EU funding have cleaner cap tables and their tech has already been validated! Dealflow.eu helps you navigate these investment opportunities.
In 2022, a total of 46 startups and spinoffs pitched for 8 e-pitching events in verticals as diverse as Sustainability, Health, DeepTech, Biotech, Mobility and Food & Agritech. In addition, some of the most compelling EU-funded innovators got to pitch in the annual Innovation Radar Prize that Dealflow.eu organised. Our agenda is constantly updated, so take a look at our past and future events here.
"Our vision is to create true clinical impact – and do this at a broad scale. To this end, NVision will both support its users, e.g., through scientific and regulatory as well as funding support, and support the development of novel clinical applications within and beyond oncology."
If you want to get in touch with this company, please feel free to reach out at info@dealflow.eu
"In construction, Svelte facilitates the production of moulds for casting resource-efficient concrete elements (...) that have been topologically optimised to use 40% less concrete (...) More importantly, in the view that the construction industry is the world’s biggest CO2, NOX & PM10 generator (...) eliminating waste at the design stage has the largest savings potential in construction and can cut GHG emissions by 18%."
If you want to get in touch with this company, please feel free to reach out at info@dealflow.eu
“Healthentia solution has been validated since 2019 as an electronic Patient Report Outcome (ePRO) solution for the purposes of a clinical study of a Top5 Pharma and since then it has been used in various studies and patient support programs by hospitals, health organizations and pharmaceutical companies (...)"
If you want to get in touch with this company, please feel free to reach out at info@dealflow.eu
"Currently, two similar ideas are being developed in the United States (...) These projects are trying to store energy in graphite blocks at high temperatures, while we use fused silicon. The advantage of silicon is that it can store much more energy per volume unit. This means that our solution can have a smaller size and therefore also smaller investment costs."
If you want to get in touch with this company, please feel free to reach out at info@dealflow.eu
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Directorate-General for Communications Networks, Content and Technology. Neither the European Union nor the granting authority can be held responsible for them.
You are receiving this newsletter because you are subscribbed to the Dealflow.eu mailing list.
